Saxenda is still prescribed today, but for most patients it has largely been superseded by the newer, more effective GLP-1 options now available
The article points to insulin resistance, chronic inflammation, thyroid dysfunction, and nutritional deficiencies as metabolic states that can dampen efficacy
If the protocol concerns you or conflicts with your current injection schedule, raise it with your prescribing physician before starting
Monitorear sntomas de pancreatitis aguda, hipoglucemia severa (en combinacin con sulfonilureas o insulina) y alteraciones visuales
The article's comparison table lists a microdose protocol as potentially suiting patients with reduced metabolic reserve, with the possibility of fewer side effects
Redness, swelling, or bruising at the injection site